Sznol, M: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Traces of the Targum Sources in Greek Bible Translations in the Hebrew Alphabet

Journal:

Journal for the Study of the Pseudepigrapha

Year:

2014

Language:

english

File:

PDF, 280 KB

english, 2014

2

Clinical Experiences With Anti-CD137 and Anti-PD1 Therapeutic Antibodies

Paolo A. Ascierto, Ester Simeone, Mario Sznol, Yang-Xin Fu, Ignacio Melero

Journal:

Seminars in Oncology

Year:

2010

Language:

english

File:

PDF, 254 KB

english, 2010

3

Combination Therapy with Anti-CTLA-4 and Anti-PD-1 Leads to Distinct Immunologic Changes In Vivo

Das, R., Verma, R., Sznol, M., Boddupalli, C. S., Gettinger, S. N., Kluger, H., Callahan, M., Wolchok, J. D., Halaban, R., Dhodapkar, M. V., Dhodapkar, K. M.

Journal:

The Journal of Immunology

Year:

2015

Language:

english

File:

PDF, 1.09 MB

english, 2015

4

Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer

Sznol, M., Chen, L.

Journal:

Clinical Cancer Research

Year:

2013

Language:

english

File:

PDF, 661 KB

english, 2013

5

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.

Fyfe, G, Fisher, R I, Rosenberg, S A, Sznol, M, Parkinson, D R, Louie, A C

Journal:

Journal of Clinical Oncology

Year:

1995

Language:

english

File:

PDF, 702 KB

english, 1995

6

Introducing a New Series: Immunotherapy Facts and Hopes

Melero, Ignacio, Sznol, Mario, Tessmer, Marlowe S., Whiteside, Theresa L., Wolchok, Jedd D.

Journal:

Clinical Cancer Research

Year:

2018

Language:

english

File:

PDF, 163 KB

english, 2018

7

Erythropoietin production. A potential marker for interleukin-2/interferon-responsive tumors

John E. Janik, William H. Sharfman, John W. Smitht II, Dan L. Longo, Mario Sznol, Walter J. Urba, Robert Figlin, William C. Pierce, Ronald M. Bukowski, Gwen Fyfe, Arie Belldegrun

Journal:

Year:

1993

Language:

english

File:

PDF, 433 KB

english, 1993

8

A phase II trial of extracorporeal plasma immunoadsorption of patient plasma with prosorba columns for treating metastatic breast cancer

David W. Fennelly, Larry Norton, Mario Sznol, Thomas B. Hakes

Journal:

Year:

1995

Language:

english

File:

PDF, 350 KB

english, 1995

9

A phase 2 trial of dasatinib in advanced melanoma

Harriet M. Kluger, Arkadiuz Z. Dudek, Carrie McCann, Jean Ritacco, Nadine Southard, Lucia B. Jilaveanu, Annette Molinaro, Mario Sznol

Journal:

Year:

2011

Language:

english

File:

PDF, 140 KB

english, 2011

10

Phase I and pharmacokinetic study of Triapine®, a potent ribonucleotide reductase inhibitor, in adults with advanced hematologic malignancies

Ivana Gojo, Michael L. Tidwell, Jacqueline Greer, Naoko Takebe, Karen Seiter, Mary F. Pochron, Bonny Johnson, Mario Sznol, Judith E. Karp

Journal:

Leukemia Research

Year:

2007

Language:

english

File:

PDF, 712 KB

english, 2007

11

A Phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disorders

Judith E. Karp, Francis J. Giles, Ivana Gojo, Lawrence Morris, Jacqueline Greer, Bonny Johnson, Mya Thein, Mario Sznol, Jennifer Low

Journal:

Leukemia Research

Year:

2008

Language:

english

File:

PDF, 117 KB

english, 2008

12

A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancer

Yun Yen, Kim Margolin, James Doroshow, Mayer Fishman, Bonny Johnson, Caroline Clairmont, Dan Sullivan, Mario Sznol

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2004

Language:

english

File:

PDF, 233 KB

english, 2004

13

A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer

John Murren, Manuel Modiano, Shivaani Kummar, Caroline Clairmont, Merrill Egorin, Edward Chu, Mario Sznol

Journal:

Investigational New Drugs

Year:

2005

Language:

english

File:

PDF, 273 KB

english, 2005

14

Betting on immunotherapy for melanoma

Journal:

Current Oncology Reports

Year:

2009

Language:

english

File:

PDF, 298 KB

english, 2009

15

Classification of renal cell carcinoma based on expression of VEGF and VEGF receptors in both tumor cells and endothelial cells

Kluger, Harriet M, Siddiqui, Summar F, Angeletti, Cesar, Sznol, Mario, Kelly, William K, Molinaro, Annette M, Camp, Robert L

Journal:

Laboratory Investigation

Year:

2008

Language:

english

File:

PDF, 607 KB

english, 2008

16

Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients

Nemunaitis, John, Cunningham, Casey, Senzer, Neil, Kuhn, Joseph, Cramm, Jennifer, Litz, Craig, Cavagnolo, Robert, Cahill, Ann, Clairmont, Caroline, Sznol, Mario

Journal:

Cancer Gene Therapy

Year:

2003

Language:

english

File:

PDF, 146 KB

english, 2003

17

Advances in the Treatment of Metastatic Melanoma: New Immunomodulatory Agents

Journal:

Seminars in Oncology

Year:

2012

Language:

english

File:

PDF, 323 KB

english, 2012

18

Melanoma Brain Metastases: Is It Time to Reassess the Bias?

Jaclyn C. Flanigan, Lucia B. Jilaveanu, Mark Faries, Mario Sznol, Stephan Ariyan, James B. Yu, Jonathan P.S. Knisely, Veronica L. Chiang, Harriet M. Kluger

Journal:

Current Problems in Cancer

Year:

2011

Language:

english

File:

PDF, 311 KB

english, 2011

19

Selective accumulation of attenuated Salmonella in solid tumors - a new anti-cancer vector

Mario Sznol, John Mao, Susan MacDonald, Ivan King

Journal:

European Journal of Cancer

Year:

2001

Language:

english

File:

PDF, 82 KB

english, 2001

20

Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial

Kim Margolin, Marc S Ernstoff, Omid Hamid, Donald Lawrence, David McDermott, Igor Puzanov, Jedd D Wolchok, Joseph I Clark, Mario Sznol, Theodore F Logan, Jon Richards, Tracy Michener, Agnes Balogh, Ke

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 129 KB

english, 2012

21

PLX4032, a selective BRAFV600E kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAFWT melanoma cells

Ruth Halaban, Wengeng Zhang, Antonella Bacchiocchi, Elaine Cheng, Fabio Parisi, Stephan Ariyan, Michael Krauthammer, James P. McCusker, Yuval Kluger, Mario Sznol

Journal:

Pigment Cell & Melanoma Research

Year:

2010

Language:

english

File:

PDF, 921 KB

english, 2010

22

In vitro studies of dasatinib, its targets and predictors of sensitivity

Lucia B. Jilaveanu, Christopher R. Zito, Saadia A. Aziz, Ashok Chakraborty, Michael A. Davies, Robert L. Camp, David L. Rimm, Arkadiusz Dudek, Mario Sznol, Harriet M. Kluger

Journal:

Pigment Cell & Melanoma Research

Year:

2011

Language:

english

File:

PDF, 118 KB

english, 2011

23

Outcomes of Melanoma Brain Metastasis Management with Gamma Knife Radiosurgery +/- Ipilimumab

J. Knisely, V.L.S. Chiang, H.M. Kluger, J.C. Flanigan, M. Sznol, J.B. Yu

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

24

CD70 expression patterns in renal cell carcinoma

Lucia B. Jilaveanu, Joshua Sznol, Saadia A. Aziz, Dylan Duchen, Harriet M. Kluger, Robert L. Camp

Journal:

Human Pathology

Year:

2012

Language:

english

File:

PDF, 301 KB

english, 2012

25

The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization

Harriet M Kluger, Mary M McCarthy, Ayesha B Alvero, Mario Sznol, Stephan Ariyan, Robert L Camp, David L Rimm, Gil Mor

Journal:

Journal of Translational Medicine

Year:

2007

Language:

english

File:

PDF, 4.49 MB

english, 2007

26

Melanoma: A model for testing new agents in combination therapies

Paolo A Ascierto, Howard Z Streicher, Mario Sznol

Journal:

Journal of Translational Medicine

Year:

2010

Language:

english

File:

PDF, 668 KB

english, 2010

27

Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032

Jill C Rubinstein, Mario Sznol, Anna C Pavlick, Stephan Ariyan, Elaine Cheng, Antonella Bacchiocchi, Harriet M Kluger, Deepak Narayan, Ruth Halaban

Journal:

Journal of Translational Medicine

Year:

2010

Language:

english

File:

PDF, 918 KB

english, 2010

28

Expression of drug targets in primary and matched metastatic renal cell carcinoma tumors

Saadia A Aziz, Joshua A Sznol, Adebowale Adeniran, Fabio Parisi…

Journal:

BMC Clinical Pathology

Year:

2013

Language:

english

File:

PDF, 336 KB

english, 2013

29

Vascularity of primary and metastatic renal cell carcinoma specimens

Saadia A Aziz, Joshua Sznol, Adebowale Adeniran…

Journal:

Journal of Translational Medicine

Year:

2013

Language:

english

File:

PDF, 530 KB

english, 2013

30

Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma

Aziz, Saadia A, Sznol, Joshua A, Albiges, Laurence, Zito, Christopher, Jilaveanu, Lucia B, Camp, Robert L, Escudier, Bernard, Kluger, Harriet M

Journal:

Cancer Cell International

Year:

2014

Language:

english

File:

PDF, 488 KB

english, 2014

31

Programmed death ligand-1 expression in non-small cell lung cancer

Velcheti, Vamsidhar, Schalper, Kurt A, Carvajal, Daniel E, Anagnostou, Valsamo K, Syrigos, Konstantinos N, Sznol, Mario, Herbst, Roy S, Gettinger, Scott N, Chen, Lieping, Rimm, David L

Journal:

Laboratory Investigation

Year:

2014

Language:

english

File:

PDF, 498 KB

english, 2014

32

White Paper on Adoptive Cell Therapy for Cancer with Tumor-Infiltrating Lymphocytes: A Report of the CTEP Subcommittee on Adoptive Cell Therapy

Weber, J., Atkins, M., Hwu, P., Radvanyi, L., Sznol, M., Yee, C.

Journal:

Clinical Cancer Research

Year:

2011

Language:

english

File:

PDF, 234 KB

english, 2011

33

9306 Phase II multi-institution trial of ipilimumab for patients with melanoma and brain metastasis

Margolin, K., Lawrence, D., Hamid, O., McDermott, D., Puzanov, I., Sznol, M., Richards, J., Clark, J., Logan, T., Hodi, S.

Journal:

European Journal of Cancer Supplements

Year:

2009

Language:

english

File:

PDF, 49 KB

english, 2009

34

Review of interleukin-2 alone and interleukin-2/LAK clinical trials in metastatic malignant melanoma

Sznol, Mario, Dutcher, Janice P., Atkins, Michael B., Rayner, Anthony R.A., Margolin, Kim A., Gaynor, Ellen R., Weiss, Geoffrey R., Aronson, Fred, Parkinson, David R., Hawkins, Michael J.

Journal:

Cancer Treatment Reviews

Year:

1989

Language:

english

File:

PDF, 730 KB

english, 1989

35

Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Advanced Melanoma

Ott, P. A., Hamid, O., Pavlick, A. C., Kluger, H., Kim, K. B., Boasberg, P. D., Simantov, R., Crowley, E., Green, J. A., Hawthorne, T., Davis, T. A., Sznol, M., Hwu, P.

Journal:

Journal of Clinical Oncology

Year:

2014

Language:

english

File:

PDF, 254 KB

english, 2014

36

Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab

Topalian, S. L., Sznol, M., McDermott, D. F., Kluger, H. M., Carvajal, R. D., Sharfman, W. H., Brahmer, J. R., Lawrence, D. P., Atkins, M. B., Powderly, J. D., Leming, P. D., Lipson, E. J., Puzanov, I

Journal:

Journal of Clinical Oncology

Year:

2014

Language:

english

File:

PDF, 2.14 MB

english, 2014

37

Tumour therapy using Salmonella

King, I, Luo, X, Feng, M, Ittensohn, M, Li, Z, Belcourt, M, Lin, S, Le, T, Pike, J, Troy, K, Sznol, M, Clairmont, C, Bermudes, D, Zheng, L-M

Journal:

Expert Opinion on Emerging Drugs

Year:

2000

Language:

english

File:

PDF, 145 KB

english, 2000

38

Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab

Yuan, J., Adamow, M., Ginsberg, B. A., Rasalan, T. S., Ritter, E., Gallardo, H. F., Xu, Y., Pogoriler, E., Terzulli, S. L., Kuk, D., Panageas, K. S., Ritter, G., Sznol, M., Halaban, R., Jungbluth, A.

Journal:

Proceedings of the National Academy of Sciences

Year:

2011

Language:

english

File:

PDF, 590 KB

english, 2011

39

A Phase I Trial of B7-Transfected or Parental Lethally Irradiated Allogeneic Melanoma Cell Lines to Induce Cell-Mediated Immunity Against Tumor-Associated Antigen Presented by HLA-A2 or HLA-A1 in Patients with Stage IV Melanoma. National Institutes of Health, Bethesda, Maryland

Fenton, Robert T., Sznol, Mario, Luster, Douglas G., Taub, Dennis D., Longo, Dan L.

Journal:

Human Gene Therapy

Year:

1995

Language:

english

File:

PDF, 1.94 MB

english, 1995

40

Combined BRAF (Dabrafenib) and MEK Inhibition (Trametinib) in Patients With BRAFV600-Mutant Melanoma Experiencing Progression With Single-Agent BRAF Inhibitor

Johnson, D. B., Flaherty, K. T., Weber, J. S., Infante, J. R., Kim, K. B., Kefford, R. F., Hamid, O., Schuchter, L., Cebon, J., Sharfman, W. H., McWilliams, R. R., Sznol, M., Lawrence, D. P., Gibney,

Journal:

Journal of Clinical Oncology

Year:

2014

Language:

english

File:

PDF, 353 KB

english, 2014

41

Phase I and Pharmacokinetic Study of the Ribonucleotide Reductase Inhibitor, 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone, Administered by 96-Hour Intravenous Continuous Infusion

Wadler, S., Makower, D., Clairmont, C., Lambert, P., Fehn, K., Sznol, M.

Journal:

Journal of Clinical Oncology

Year:

2004

Language:

english

File:

PDF, 235 KB

english, 2004

42

Role of Chitinase 3-like-1 and Semaphorin 7a in Pulmonary Melanoma Metastasis

Ma, B., Herzog, E. L., Lee, C. G., Peng, X., Lee, C.-M., Chen, X., Rockwell, S., Koo, J. S., Kluger, H., Herbst, R. S., Sznol, M., Elias, J. A.

Journal:

Cancer Research

Year:

2015

Language:

english

File:

PDF, 6.57 MB

english, 2015

43

Release the Hounds! Activating the T-Cell Response to Cancer

Sznol, Mario, Longo, Dan L.

Journal:

New England Journal of Medicine

Year:

2015

Language:

english

File:

PDF, 365 KB

english, 2015

44

MicroRNA signatures differentiate melanoma subtypes

Chan, Elcie, Patel, Rajeshvari, Nallur, Sunitha, Ratner, Elena, Bacchiocchi, Antonella, Hoyt, Kathleen, Szpakowski, Sebastian, Godshalk, Sirie, Ariyan, Stephan, Sznol, Mario, Halaban, Ruth, Krauthamme

Journal:

Year:

2011

Language:

english

File:

PDF, 2.16 MB

english, 2011

45

C-Raf Is Associated with Disease Progression and Cell Proliferation in a Subset of Melanomas

Jilaveanu, L. B., Zito, C. R., Aziz, S. A., Conrad, P. J., Schmitz, J. C., Sznol, M., Camp, R. L., Rimm, D. L., Kluger, H. M.

Journal:

Clinical Cancer Research

Year:

2009

Language:

english

File:

PDF, 487 KB

english, 2009

46

Plasma Markers for Identifying Patients with Metastatic Melanoma

Kluger, H. M., Hoyt, K., Bacchiocchi, A., Mayer, T., Kirsch, J., Kluger, Y., Sznol, M., Ariyan, S., Molinaro, A., Halaban, R.

Journal:

Clinical Cancer Research

Year:

2011

Language:

english

File:

PDF, 530 KB

english, 2011

47

Characterization of PD-L1 Expression and Associated T-cell Infiltrates in Metastatic Melanoma Samples from Variable Anatomic Sites

Kluger, H. M., Zito, C. R., Barr, M. L., Baine, M. K., Chiang, V. L. S., Sznol, M., Rimm, D. L., Chen, L., Jilaveanu, L. B.

Journal:

Clinical Cancer Research

Year:

2015

Language:

english

File:

PDF, 9.22 MB

english, 2015

48

Expanded Use Trials—Are There Better Approaches to Minimize Adverse Consequences to the Clinical Trials Program?

Journal:

The Cancer Journal

Year:

2014

Language:

english

File:

PDF, 140 KB

english, 2014

49

Ipilimumab-induced Perforating Colitis

Mitchell, Kisha A., Kluger, Harriet, Sznol, Mario, Hartman, Douglas J.

Journal:

Journal of Clinical Gastroenterology

Year:

2013

Language:

english

File:

PDF, 584 KB

english, 2013

50

Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab

McDermott, D. F., Drake, C. G., Sznol, M., Choueiri, T. K., Powderly, J. D., Smith, D. C., Brahmer, J. R., Carvajal, R. D., Hammers, H. J., Puzanov, I., Hodi, F. S., Kluger, H. M., Topalian, S. L., Pa

Journal:

Journal of Clinical Oncology

Year:

2015

Language:

english

File:

PDF, 821 KB

english, 2015

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски